bpc 157 delayed release InfiniWell has the largest portfolio of BPC-157 products on the market, providing total flexibility for tailored patient protocols. Consider this unique peptide for patients requiring support in the areas of: joint and Size:1000 mcg/ml - 30 ml x 5

Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing | Cell and Tissue Research | Springer Nature Link

Example: Prednisone-induced diabetes, no complications, patient started on insulin: T38.0X5A (adverse effect, glucocorticoids, initial encounter) E09.9 (drug-induced diabetes, no complications) Z79.4 (long-term insulin use) Example: Steroid-induced diabetes with polyneuropathy: T38.0X5A E09.42 (drug-induced diabetes with polyneuropathy) Z79.4 (if on insulin) The Most Common Error Here Defaulting to E11 because the patient is a “new diabetic.” If steroids caused the diabetes, E09 is always correct regardless of the patient’s age, weight, or family history

10ml Ampoule water for injection

Size:1000 mcg/ml - 30 ml x 5

Storage & Handling To help maintain product quality and sterility: Store according to laboratory storage requirements